What is the typical hemolytic (breakdown of red blood cells) workup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hemolytic Workup

The hemolytic workup should include: CBC with reticulocyte count, lactate dehydrogenase (LDH), unconjugated bilirubin, haptoglobin, direct antiglobulin test (DAT/Coombs), and peripheral blood smear—these tests confirm hemolysis and differentiate immune from non-immune causes. 1

Initial Laboratory Tests to Confirm Hemolysis

The first step is establishing that hemolysis is actually occurring:

  • Reticulocyte count is typically elevated (>2%), indicating the bone marrow is responding appropriately to red cell destruction 1, 2
  • Lactate dehydrogenase (LDH) is elevated due to release from lysed red cells 1, 3
  • Unconjugated (indirect) bilirubin is increased from breakdown of hemoglobin 1, 2
  • Haptoglobin is decreased or absent because it binds free hemoglobin released during hemolysis 1, 3
  • Complete blood count (CBC) confirms anemia and determines if it is normocytic or macrocytic (hemolysis typically presents as normocytic or macrocytic) 1, 2

Common pitfall: Reticulocytosis may be absent or inadequate in 20-40% of autoimmune hemolytic anemia cases, particularly when there is concurrent bone marrow involvement, nutritional deficiency, or autoimmune reaction against marrow precursors—this is a poor prognostic sign. 3

Distinguishing Immune from Non-Immune Causes

Once hemolysis is confirmed, the next critical step is determining the mechanism:

  • Direct antiglobulin test (DAT/Coombs test) is essential to distinguish immune-mediated hemolysis from non-immune causes 1, 2
  • A positive DAT indicates antibodies or complement on red cell surfaces, suggesting autoimmune hemolytic anemia, drug-induced hemolysis, or transfusion reaction 2, 4
  • A negative DAT points toward hereditary causes (membranopathies, enzymopathies, hemoglobinopathies) or non-immune extrinsic causes 5, 2

Peripheral Blood Smear Evaluation

Peripheral blood smear examination is mandatory as red cell morphology provides crucial diagnostic clues:

  • Spherocytes suggest hereditary spherocytosis or autoimmune hemolytic anemia 1, 4
  • Schistocytes (fragmented cells) indicate microangiopathic hemolytic anemia or mechanical trauma 2, 4
  • Sickle cells point to sickle cell disease 4
  • Bite cells or blister cells suggest G6PD deficiency with oxidative stress 2
  • Echinocytes may be seen in pyruvate kinase deficiency, especially post-splenectomy 5

Important caveat: In pyruvate kinase deficiency and other enzymopathies, red cell morphology is often unremarkable with only nonspecific anisocytosis and poikilocytosis, making these conditions easy to miss. 5

Additional Testing Based on Initial Results

For Suspected Immune Hemolysis (DAT Positive):

  • Evaluate for underlying autoimmune disorders, malignancies, or drug exposures 2, 4
  • Consider warm vs. cold antibody testing based on clinical presentation 2

For Suspected Hereditary Hemolysis (DAT Negative):

  • Red cell enzyme assays for pyruvate kinase deficiency and G6PD deficiency are essential 1
  • Molecular/genetic testing for specific mutations when hereditary hemolytic anemia is suspected 1
  • Osmotic fragility testing may be helpful but can be normal or altered in pyruvate kinase deficiency, limiting its utility 5

For Suspected Intravascular Hemolysis:

  • Hemoglobinuria and hemosiderinuria indicate severe intravascular hemolysis 3, 6
  • Flow cytometry for paroxysmal nocturnal hemoglobinuria (PNH) screening when intravascular hemolysis is present 1
  • Marked LDH elevation is typical of intravascular hemolysis 3

Supplementary Studies

  • Iron studies (serum ferritin, transferrin saturation) may be disproportionately elevated in chronic hemolysis, even without transfusion history 5, 1
  • Vitamin B12 and folate levels rule out other causes of macrocytic anemia 1
  • Bone marrow examination is indicated when there is suspicion of infiltrative disease, ineffective erythropoiesis, or unexplained reticulocytopenia 1

Critical Timing Considerations

Recent blood transfusion significantly affects test results, particularly the DAT and enzyme assays, potentially obscuring the diagnosis. 1 Ideally, obtain pre-transfusion samples when hemolysis is suspected, though this should not delay life-saving transfusion in severe cases.

Family History and Special Populations

  • Obtain detailed family history to identify potential hereditary causes, as many enzymopathies and membranopathies follow autosomal recessive or dominant patterns 1
  • In transfusion-dependent patients with undiagnosed anemia, consider rare enzymopathies like pyruvate kinase deficiency, which may present with features mimicking congenital dyserythropoietic anemias 5, 1

References

Guideline

Hemolytic Anemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hemolytic Anemia: Evaluation and Differential Diagnosis.

American family physician, 2018

Research

Hemolytic anemia.

American family physician, 2004

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hemolytic anemias. Diagnosis and management.

The Medical clinics of North America, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.